Clinical Trial Update: Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing intraoperative ticagrelor versus clopidogrel to evaluate antiplatelet effects and safety in coronary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: Yongjian Wu | Conditions: Coronary Disease | Phase 4 | Status: UNKNOWN